Plain-English translation of NCT07012772 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a device called the COMBO Endoscopy Oropharyngeal Airway to prevent dangerously low oxygen levels during a common procedure (called ERCP) that treats blocked bile ducts. The procedure uses sedation to keep you comfortable, but sedation can sometimes lower oxygen levels in the blood. This new device is designed to monitor your breathing and provide extra oxygen support throughout the procedure.
Low oxygen levels are a common problem during this type of procedure under sedation, and researchers want to find better ways to keep patients safe. This device was created specifically for endoscopic procedures to manage the airway, monitor breathing, and provide oxygen support in one tool.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive your scheduled bile duct procedure as planned, but with the new COMBO breathing device in place during the procedure. The device will monitor your oxygen levels and breathing throughout the procedure, which should not exceed 45 minutes. The study team will watch your oxygen levels closely and collect information about how well the device works to keep your oxygen levels stable during and after the procedure.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China